关于公司
Starton Therapeutics is a biotechnology company focused on transforming the standard of care therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting. It uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority for patients with hematological malignancies. Starton Therapeutics was established in 2017 and is headquartered in New York.
US
未知
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论